Clinical Trials Logo

Testicular Seminoma clinical trials

View clinical trials related to Testicular Seminoma.

Filter by:
  • None
  • Page 1

NCT ID: NCT01434355 Completed - Clinical trials for Childhood Malignant Ovarian Germ Cell Tumor

DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or Siblings

Start date: November 1, 2011
Phase:
Study type: Observational

This research trial studies deoxyribonucleic acid (DNA) samples from younger patients with germ cell tumor and their parents or siblings. Studying samples of tumor tissue and saliva from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

NCT ID: NCT00042952 Terminated - Clinical trials for Recurrent Ovarian Germ Cell Tumor

Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer

Start date: June 2002
Phase: Phase 2
Study type: Interventional

Imatinib mesylate may stop the growth of tumor cells by blocking the enzymes necessary for tumor cell growth. Phase II trial to study the effectiveness of imatinib mesylate in treating patients who have progressive, refractory, or recurrent stage II or stage III testicular cancer or stage II or stage III ovarian cancer following cisplatin-based chemotherapy